Citadel Advisors
USPH icon

Citadel Advisors’s US Physical Therapy USPH Stock Holding History

Citadel Advisors’s Portfolio USPH Stock Details USPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$639K Buy
+9,300
New +$632K ﹤0.01% 9296
2026
Q1 		– Sell
-4,500
Closed -$351K – 14293
2025
Q4 		$351K Buy
+4,500
New +$365K ﹤0.01% 9805
2025
Q2 		– Sell
-1,000
Closed -$72.4K – 15231
2025
Q1 		$72.4K Buy
1,000
+400
+67% +$33.6K ﹤0.01% 11868
2024
Q4 		$53.2K Sell
600
-1,500
-71% -$134K ﹤0.01% 12327
2024
Q3 		$178K Buy
2,100
+1,900
+950% +$169K ﹤0.01% 10317
2024
Q2 		$18.5K Sell
200
-300
-60% -$30.3K ﹤0.01% 12710
2024
Q1 		$56.4K Sell
500
-600
-55% -$59.9K ﹤0.01% 12060
2023
Q4 		$102K Sell
1,100
-4,500
-80% -$396K ﹤0.01% 10907
2023
Q3 		$514K Buy
5,600
+3,600
+180% +$387K ﹤0.01% 8016
2023
Q2 		$243K Buy
2,000
+1,600
+400% +$173K ﹤0.01% 9471
2023
Q1 		$39.2K Sell
400
-100
-20% -$9.54K ﹤0.01% 12454
2022
Q4 		$40.5K Sell
500
-3,800
-88% -$319K ﹤0.01% 12404
2022
Q3 		$327K Buy
4,300
+800
+23% +$76.9K ﹤0.01% 9381
2022
Q2 		$382K Buy
+3,500
New +$372K ﹤0.01% 9242
2022
Q1 		– Sell
-2,200
Closed -$210K – 14631
2021
Q4 		$210K Buy
+2,200
New +$221K ﹤0.01% 11750
2021
Q3 		– Sell
-15,500
Closed -$1.8M – 14701
2021
Q2 		$1.8M Sell
15,500
-40,200
-72% -$4.62M ﹤0.01% 6865
2021
Q1 		$5.8M Buy
55,700
+25,700
+86% +$3.2M ﹤0.01% 3945
2020
Q4 		$3.61M Sell
30,000
-5,200
-15% -$525K ﹤0.01% 4260
2020
Q3 		$3.06M Buy
35,200
+30,700
+682% +$2.64M ﹤0.01% 3954
2020
Q2 		$365K Sell
4,500
-1,100
-20% -$80.2K ﹤0.01% 7598
2020
Q1 		$386K Buy
5,600
+2,600
+87% +$274K ﹤0.01% 6888
2019
Q4 		$343K Buy
+3,000
New +$374K ﹤0.01% 7387

Other funds holding USPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
SAM
Southernsun Asset Management Memphis, Tennessee $743M AUM 34.03% 1-Year Est. Return

Citadel Advisors's USPH Position: Q2 2026 in Review

Citadel Advisors increased its US Physical Therapy (USPH) stake by 704% in Q2 2026, buying an estimated $4.88M and bringing the position to 82,053 shares worth $5.64M. The position accounts for ﹤0.01% of the portfolio, ranked #4515.

Citadel Advisors first reported a position in USPH in Q1 2014 and has held it in 40 quarters since. The position peaked at $8.29M in Q4 2021. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Citadel Advisors held 82,053 shares of US Physical Therapy worth $5.64M as of Q2 2026.
  • Citadel Advisors bought 71,853 US Physical Therapy shares in Q2 2026, an estimated $4.88M.
  • US Physical Therapy made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4515 holding.
  • Citadel Advisors first reported a position in US Physical Therapy in Q1 2014 and has held it in 40 quarters since.
  • Citadel Advisors's US Physical Therapy position peaked at $8.29M in Q4 2021.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.